Clinical Trial Update: Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of cemiplimab (Libtayo) given before and after surgery for high-risk cutaneous squamous cell carcinoma is currently recruiting, including metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Emory University | Conditions: Metastatic Skin Squamous Cell Carcinoma, Recurrent Skin Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING